FDA Investigator Mary Ewilkerson Brinsko
Mary Ewilkerson Brinsko has conducted inspections on 160 sites in 2 countries as of 22 May 2013. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
160
Last Inspection Date:
22 May 2013
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India
FDA Investigators that have inspected at least one site in common with Mary Ewilkerson Brinsko:
Alexander M Kay,
Allen F Hall,
Amanda N Schaupp,
Amy A Johnson,
Ana Djurdjevic,
Angel K Sandhu,
Annette Melendez,
Anthony E Keller, RPh,
April P Shaw,
Armando Chavez, MS,
Arsen Karapetyan,
Beverly A Thomas,
Binh T Nguyen,
Brian P Putz,
Brien C Fox,
Bryce A May,
Carla J Lundi,
Carol B Czerniak,
Carol F Robinson,
Caryn M Mcnab,
Cathleen A Carr Sharpe,
CDR Rochelle B Young, RPh, MSA,
Celeta S Coves,
Comyar Shoghi,
Courtney N Long,
Creighton T Tuzon,
Daniel J Lahar,
Daniel W Cline,
David G Whitman,
Davis,
Deborah Kleinfeld,
Dennis M Farley,
Diana L Ayala,
Diana M Rand,
Diane Cvan Leeuwen,
Donna Ltartaglino Besone,
Dustin P Tran,
Dustin R Abaonza,
Dylan R Jock,
Edward D Harris,
Emily S Mcgann,
Eric W Anderson,
Eric Zhu,
Finn A Slizza,
Fred R Strominger,
Gabriel M Guevarra,
Gail L Katz,
Garrad R Poole,
Gene D Arcy,
Geoffrey M Leist,
Helen J Hamaoka,
Herbert E Arden,
Humberto Z Gomez,
Irina Gaberman,
Jeffrey M Watson,
Jeffrey W Shrifter, DPM,
Jennie J Fan,
Jennifer M Foley,
Jinnie Kokiatkulkij,
Joan A Loreng,
Jocelyn E Massey,
Joey V Quitania,
John A Iwen,
John A Liu,
Judy C Nepsa,
Julian C Hanson,
Ka L Wong,
Kaarin M Slotte,
Karen J Bak,
Katherine E Jacobitz,
Kathleen B Swat,
Kellie L Thommes, RN,
Kenneth S Boehnen,
Kevin T Gerrity,
Kimberly M Lichter,
Krista K Petersen,
Laura E Garcia,
Lauren E Swantko,
Laurissa S Flowers,
Laverne Kimble,
Laverne Puckett,
Lawrence H Howell,
LCDR Jennifer H Rhyu,
Lee Terry Moore,
Leonard H Lavi,
Linda F Murphy,
Linda Thai,
Maida Henesian (NMI),
Maira P Brading,
Marie K Kinkade,
Mark C Saale,
Mary T Carden,
Melissa D Kalik,
Melsomar R Ramos,
Michael A Blaine,
Michael D Garcia,
Michael Davila,
Minh D Phan,
Mizanne E Lewis,
Natalie J Ayoub,
Paul M Chefor,
Peter Kessler, PhD,
Phillip L Toy,
Quynh H Strandberg,
Raymond W Brullo,
Rebecca T Davis,
Richmond K Yip,
Robert S Sweeton,
Roberta K Smith,
Roger D Gawne,
Sandra S Saniga,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sara Jdent Acosta,
Scott K Zika,
Scott N Lim,
Sean P Desbrow,
Sergio Chavez (NMI),
Seyyida Saterfield,
Shaquenta Y Perkins,
Shelley H Beausoleil,
Shelley H Roberts,
Sheri L Stephenson,
Sherri J Jackson,
Sherri N Rohlf, MD,
Sparky L Bartee,
Stephanie A Slater, MS,
Steven E Porter, Jr,
Stuart W Russell,
Tania Y Hall,
Tawny L Colling,
Terrance L Thomas,
Terri L Jones,
Thanh B Tran,
Thanh M Andrews,
Thomas R Beilke,
Timothy P Lafave,
Tonia L Sawyer,
Trudy R Papson,
Uttaniti Limchumroon (Tom),
Vanessa R Muller,
Vickie L Anderson,
Vien Q Le,
Virgilio F Pacio, CSO,
William F Lagud, Jr,
William J Foust,
Yvette E Guillermo,
Yvonne C Wilkes
Mary Ewilkerson Brinsko's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2003 | FDA 483 | Plopper, Michael G, MD - Form 483, 2003-03-18 |
| March, 2011 | EIR | Mohamed Bidair MD - EIR, 2011-03-28 |
| January, 2013 | EIR | Children's Hospital and Research Center at Oakland - EIR, 2013-01-09 |
| March, 2011 | FDA 483 | Mohamed Bidair MD - Form 483, 2011-03-28 |
| November, 2012 | EIR | Christopher S. Hall, M.D. - EIR, 2012-11-14 |
| September, 2008 | FDA 483 | Ritchard L. Fishman, M.D. - Form 483, 2008-09-04 |
| November, 2012 | FDA 483 | Christopher S. Hall, M.D. - Form 483, 2012-11-14 |
| November, 2012 | FDA 483 Response | Christopher S. Hall, M.D. - Form 483R, 2012-12-05 |
| January, 2013 | FDA 483 | Children's Hospital and Research Center at Oakland - Form 483, 2013-01-09 |
| March, 2003 | EIR | Plopper, Michael G, MD - EIR, 2003-03-18 |
| March, 2008 | FDA 483 | Synergy Health AST, LLC - Form 483, 2008-03-26 |
| August, 2003 | FDA 483 | Noved Medical Inc - Form 483, 2003-08-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more